Advs. Simon Weintraub and Daniel Green represented China International Capital Corporation Hong Kong Securities Limited and Jefferies Hong Kong Limited, the joint sponsors (underwriters) in connection with the initial public offering of Sisram Medical – the first Israeli company to list on the Hong Kong Stock Exchange. The global offering of Sisram’s shares raised approximately US $112 million. Sisram Medical, a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., had previously acquired Alma Lasers Ltd., an international company headquartered in Israel and a global leader in the field of energy-based systems for the aesthetic and surgical markets.
In addition, our firm was involved in the process of having the State of Israel recognized as an “accepted jurisdiction” by the HKSE which will hopefully lead to future opportunities for Israeli companies seeking to list their shares on the Hong Kong Stock Exchange.
The Australian Government wants the business, investor and legal communities to grow “start-up ecosystems” and ride the high-tech boom to prosperity. Austrade is setting up five overseas Innovation Landing Pads to help Australian entrepreneurs with “market-ready start-ups” thrive. It launched the first Landing Pad in Tel Aviv, Israel, in mid-2016.
Adv. Micha Tollman's interview for the NSW Law Society Journal.
Advs. Daniel Green and Eli Greenbaum represented Oramed Pharmaceuticals, an Israeli clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, in a licensing transaction with Hefei Tianhui Incubator of Technologies Co., Ltd., of China. The agreement is worth $38 million, with future royalties, and gives HTIT exclusive rights to market Oramed’s oral insulin capsule, in China, Hong Kong and Macau. This deal is alongside a $12 million equity investment in the company.
Our office is happy to co-host an event together with the Israel-Australia chamber of commerce in the commencement of Square Peg Capital's Israeli operations. Square Peg Fund, founded and managed by leading Australian business entrepreneurs and high net worth individuals, is set to invest approximately $150 million in Israeli start-ups in the next 3 to 5 years.
Our firm hosted a delegation of Australian businessmen led by Mr Cameron Clyne, CEO of the National Australia Bank and with the participation of executives from top-tier Australian companies. The group's visit was organized by the Israel-Australia Chamber of Commerce and Adv. Micha Tollman of our firm, who specializes on the Australian market and worked for several years in Sidney, Australia, in leading global law firms. The event focused on collaboration in the fields of cyber-security, bigdata, fintech and biotech and included a lecture by Adv. Barry Levenfeld of our firm concerning investment and business opportunities in Israel.